{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:22Z","timestamp":1790716582366,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.radonc.2026.111708","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:58:51Z","timestamp":1785283131000},"page":"111708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The TFDP2-PDK3 axis drives glucose metabolic reprogramming to promote radioresistance in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"223","author":[{"given":"Qi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3298-7674","authenticated-orcid":false,"given":"Qiong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111708_b0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","article-title":"Nasopharyngeal carcinoma: an evolving paradigm","volume":"18","author":"Wong","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111708_b0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111708_b0015","doi-asserted-by":"crossref","unstructured":"Pan JJ, Ng WT, Zong JF, Chan LL, O'Sullivan B, Lin SJ et al. Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 2016; 122: 546-558.","DOI":"10.1002\/cncr.29795"},{"key":"10.1016\/j.radonc.2026.111708_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111708_b0025","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s11864-023-01101-3","article-title":"Recurrent\/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?","volume":"24","author":"Juarez-Vignon Whaley","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.radonc.2026.111708_b0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.radonc.2026.111708_b0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.radonc.2026.111708_b0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.radonc.2026.111708_b0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/2326-6066.CIR-20-0111","article-title":"Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.radonc.2026.111708_b0050","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1158\/1078-0432.CCR-17-1151","article-title":"MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer","volume":"23","author":"Gunda","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111708_b0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13046-019-1214-z","article-title":"The roles of glucose metabolic reprogramming in chemo- and radio-resistance","volume":"38","author":"Lin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111708_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2016.05.032","article-title":"EBV-LMP1 suppresses the DNA damage response through DNA-PK\/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma","volume":"380","author":"Lu","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.radonc.2026.111708_b0065","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/MCB.15.5.2536","article-title":"In vivo association of E2F and DP family proteins","volume":"15","author":"Wu","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.radonc.2026.111708_b0070","first-page":"2085","article-title":"Cloning and characterization of human DP2, a novel dimerization partner of E2F","volume":"10","author":"Zhang","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2026.111708_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.742462","article-title":"TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111708_b0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00018-004-4329-z","article-title":"Cisplatin-induced genes as potential markers for thyroid cancer","volume":"62","author":"Lapouge","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.radonc.2026.111708_b0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.2227","article-title":"Gene expression profiles in HPV-infected head and neck cancer","volume":"213","author":"Schlecht","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.radonc.2026.111708_b0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.26712","article-title":"Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2","volume":"59","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.radonc.2026.111708_b0095","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/cas.16168","article-title":"Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan-cancer","volume":"115","author":"Yang","year":"2024","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2026.111708_b0100","first-page":"1590","article-title":"Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients","volume":"40","author":"Yang","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.radonc.2026.111708_b0105","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1541-7786.MCR-17-0134","article-title":"Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.radonc.2026.111708_b0110","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"issue":"1888\u20131902","key":"10.1016\/j.radonc.2026.111708_b0115","first-page":"e1821","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2026.111708_b0120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.radonc.2026.111708_b0125","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.radonc.2026.111708_b0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.radonc.2026.111708_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf018","article-title":"edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets","volume":"53","author":"Chen","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.radonc.2026.111708_b0140","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/0008-5472.CAN-15-1023","article-title":"JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification","volume":"75","author":"Sun","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2026.111708_b0145","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","article-title":"Role of cell cycle in mediating sensitivity to radiotherapy","volume":"59","author":"Pawlik","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111708_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189023","article-title":"Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111708_b0155","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.radonc.2026.111708_b0160","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","article-title":"Advances in targeting 'undruggable' transcription factors with small molecules","volume":"20","author":"Henley","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.radonc.2026.111708_b0165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer - from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111708_b0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12964-025-02204-0","article-title":"Mannose and PMI depletion overcomes radiation resistance in HPV-negative head and neck cancer","volume":"23","author":"Wang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.radonc.2026.111708_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156102","article-title":"METTL1 mediates m7G modification of PFKFB3 mRNA to promote radioresistance in esophageal cancer by affecting glycolytic metabolism","volume":"272","author":"Xiao","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"1696\u20131710","key":"10.1016\/j.radonc.2026.111708_b0180","first-page":"e1610","article-title":"Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.radonc.2026.111708_b0185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2026.111708_b0190","doi-asserted-by":"crossref","first-page":"19772","DOI":"10.1074\/jbc.M601140200","article-title":"A new level of architectural complexity in the human pyruvate dehydrogenase complex","volume":"281","author":"Smolle","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2026.111708_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188568","article-title":"Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy","volume":"1876","author":"Anwar","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111708_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic Targeting of the Pyruvate Dehydrogenase Complex\/Pyruvate Dehydrogenase Kinase (PDC\/PDK) Axis in Cancer","volume":"109","author":"Stacpoole","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"Pt 1","key":"10.1016\/j.radonc.2026.111708_b0205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bj3290191","article-title":"Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex","volume":"329","author":"Bowker-Kinley","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.radonc.2026.111708_b0210","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ajpath.2011.05.050","article-title":"Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer","volume":"179","author":"Lu","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.radonc.2026.111708_b0215","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.prp.2016.10.006","article-title":"Frequent overexpression of PDK1 in primary nasopharyngeal carcinoma is associated with poor prognosis","volume":"212","author":"Xiang","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.radonc.2026.111708_b0220","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hed.27053","article-title":"Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"44","author":"Zhang","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2026.111708_b0225","doi-asserted-by":"crossref","first-page":"15773","DOI":"10.1074\/jbc.M909488199","article-title":"Marked differences between two isoforms of human pyruvate dehydrogenase kinase","volume":"275","author":"Baker","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026005475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:35:35Z","timestamp":1790714135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026005475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0167814026005475"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111708","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TFDP2-PDK3 axis drives glucose metabolic reprogramming to promote radioresistance in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111708"}}